BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23789950)

  • 1. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.
    Shah K; Abbruscato T
    Curr Pharm Des; 2014; 20(10):1510-22. PubMed ID: 23789950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes.
    Sifat AE; Vaidya B; Villalba H; Albekairi TH; Abbruscato TJ
    Am J Physiol Cell Physiol; 2019 Jan; 316(1):C2-C15. PubMed ID: 30207783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
    Tornabene E; Brodin B
    J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier Na transporters in ischemic stroke.
    O'Donnell ME
    Adv Pharmacol; 2014; 71():113-46. PubMed ID: 25307215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice.
    Shah KK; Boreddy PR; Abbruscato TJ
    Fluids Barriers CNS; 2015 Apr; 12():10. PubMed ID: 25925411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
    Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the ischemic brain.
    Thompson BJ; Ronaldson PT
    Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
    Pardridge WM
    Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial approaches for the identification of brain drug delivery targets.
    Stutz CC; Zhang X; Shusta EV
    Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting transporters for CNS drug delivery.
    Ronaldson PT
    Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity.
    Doeppner TR; Kaltwasser B; Kuckelkorn U; Henkelein P; Bretschneider E; Kilic E; Hermann DM
    Mol Neurobiol; 2016 Nov; 53(9):6332-6341. PubMed ID: 26572637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier dysfunction and recovery after ischemic stroke.
    Jiang X; Andjelkovic AV; Zhu L; Yang T; Bennett MVL; Chen J; Keep RF; Shi Y
    Prog Neurobiol; 2018; 163-164():144-171. PubMed ID: 28987927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphrinB2 Activation Enhances Vascular Repair Mechanisms and Reduces Brain Swelling After Mild Cerebral Ischemia.
    Ghori A; Freimann FB; Nieminen-Kelhä M; Kremenetskaia I; Gertz K; Endres M; Vajkoczy P
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):867-878. PubMed ID: 28254815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CNS transporters for treatment of neurodegenerative diseases.
    Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
    Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapeutic Effects of Leonurine On Ischemic Stroke: New Mechanisms of BBB Integrity.
    Zhang QY; Wang ZJ; Sun DM; Wang Y; Xu P; Wu WJ; Liu XH; Zhu YZ
    Oxid Med Cell Longev; 2017; 2017():7150376. PubMed ID: 28690765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y; Liu L
    Adv Drug Deliv Rev; 2012 May; 64(7):640-65. PubMed ID: 22154620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.
    Sifat AE; Vaidya B; Abbruscato TJ
    AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic Opportunities.
    Al-Ahmady ZS; Jasim D; Ahmad SS; Wong R; Haley M; Coutts G; Schiessl I; Allan SM; Kostarelos K
    ACS Nano; 2019 Nov; 13(11):12470-12486. PubMed ID: 31693858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier.
    Doll DN; Hu H; Sun J; Lewis SE; Simpkins JW; Ren X
    Stroke; 2015 Jun; 46(6):1681-9. PubMed ID: 25922503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection via AT
    Bennion DM; Steckelings UM; Sumners C
    Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.